KLK3 and neoplasm: Notably, prostatic ALA was positively associated with biomarkers of aggressive prostate cancer (prostate-specific antigen (PSA) and tumor proliferation rates), suggesting that prostatic ALA metabolism may be linked to disease aggressiveness.